Vivus Weight–Loss Pill Is Second in Month to Win Approval

The decision means overweight consumers can soon choose between Qsymia and Belviq, a diet drug from Arena Pharmaceuticals Inc. (ARNA) (ARNA) and Eisai Co. (4523) approved on June 27. … the potential hazards. “Weight–loss drugs have the potential to …
See all stories on this topic »